Skip to main content
Top
Published in: Heart and Vessels 9/2016

01-09-2016 | Original Article

Stroke prevention following modified endoscopic ablation and appendectomy for atrial fibrillation

Authors: Nan Ma, Zhaolei Jiang, Fei Chen, Hang Yin, Fangbao Ding, Ju Mei

Published in: Heart and Vessels | Issue 9/2016

Login to get access

Abstract

We reported the results of stroke prevention following modified endoscopic procedure for atrial fibrillation. 82 patients underwent modified endoscopic procedure for atrial fibrillation (AF), in whom 47 had paroxysmal, 28 had persistent, and 7 had long-standing atrial fibrillation. CHA2DS2VASC median score was 3 (range from 0 to 8). The procedure was performed on the beating heart, through 3 ports on the left chest wall. Pulmonary vein isolation and ablation of the left atrium were achieved by bipolar radiofrequency ablation. Left atrial appendage (LAA) was excluded by stapler. Brain CT, cardiac CT and 24-h Holter monitoring were performed following the procedure. The procedure was successfully completed for all patients. The mean duration was 122 ± 40.1 min. LAA was excluded after appendectomy and checked by intraoperative transesophageal echocardiography. The mean follow-up duration was 24.3 ± 3.5 months. No patients showed signs and symptoms of transient ischemic attack or stroke. No new positive findings were demonstrated by recurring brain CT scan performed after the procedure. Cardiac CT confirmed the absence of LAA and thrombosis in the left atrium. 87.8 % (72/82) of all patients were in sinus rhythm. Our results demonstrate that the modified endoscopic procedure is a safe, effective, and appropriate treatment for AF, which restores sinus rhythm and may be associated with the prevention of AF-related stroke.
Literature
1.
go back to reference Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375CrossRefPubMed Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375CrossRefPubMed
2.
go back to reference Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369–2429CrossRefPubMed Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369–2429CrossRefPubMed
3.
go back to reference (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449–1457 (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449–1457
4.
go back to reference Ganesan AN, Shipp NJ, Brooks AG, Kuklik P, Lau DH, Lim HS, Sullivan T, Roberts-Thomson KC, Sanders P (2013) Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc 2:e004549CrossRefPubMedPubMedCentral Ganesan AN, Shipp NJ, Brooks AG, Kuklik P, Lau DH, Lim HS, Sullivan T, Roberts-Thomson KC, Sanders P (2013) Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc 2:e004549CrossRefPubMedPubMedCentral
5.
go back to reference Whitlock RP, Hanif H, Danter M (2013) Nonpharmacologic approaches to stroke prevention in atrial fibrillation. Can J Cardiol 29:S79–S86CrossRefPubMed Whitlock RP, Hanif H, Danter M (2013) Nonpharmacologic approaches to stroke prevention in atrial fibrillation. Can J Cardiol 29:S79–S86CrossRefPubMed
6.
go back to reference Onalan O, Crystal E (2007) Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Stroke 38:624–630CrossRefPubMed Onalan O, Crystal E (2007) Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Stroke 38:624–630CrossRefPubMed
7.
go back to reference Ohtsuka T, Ninomiya M, Nonaka T, Hisagi M, Ota T, Mizutani T (2013) Thoracoscopic stand-alone left atrial appendectomy for thromboembolism prevention in nonvalvular atrial fibrillation. J Am Coll Cardiol 62:103–107CrossRefPubMed Ohtsuka T, Ninomiya M, Nonaka T, Hisagi M, Ota T, Mizutani T (2013) Thoracoscopic stand-alone left atrial appendectomy for thromboembolism prevention in nonvalvular atrial fibrillation. J Am Coll Cardiol 62:103–107CrossRefPubMed
8.
go back to reference Ma N, Ding F, Jiang Z, Chen Y, Hu F, Mei J (2012) Totally endoscopic ablation of left atrium via left chest for lone atrial fibrillation. Innovations (Phila) 7:382–384CrossRef Ma N, Ding F, Jiang Z, Chen Y, Hu F, Mei J (2012) Totally endoscopic ablation of left atrium via left chest for lone atrial fibrillation. Innovations (Phila) 7:382–384CrossRef
9.
go back to reference Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D (2012) 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 14:528–606CrossRef Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D (2012) 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 14:528–606CrossRef
10.
go back to reference Wolf PA, Mitchell JB, Baker CS, Kannel WB, D’Agostino RB (1998) Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 158:229–234CrossRefPubMed Wolf PA, Mitchell JB, Baker CS, Kannel WB, D’Agostino RB (1998) Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 158:229–234CrossRefPubMed
11.
go back to reference Alli O, Holmes DR Jr (2012) Left atrial appendage occlusion for stroke prevention. Curr Probl Cardiol 37:405–441CrossRefPubMed Alli O, Holmes DR Jr (2012) Left atrial appendage occlusion for stroke prevention. Curr Probl Cardiol 37:405–441CrossRefPubMed
12.
go back to reference Lewalter T, Ibrahim R, Albers B, Camm AJ (2013) An update and current expert opinions on percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation. Europace 15:652–656CrossRef Lewalter T, Ibrahim R, Albers B, Camm AJ (2013) An update and current expert opinions on percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation. Europace 15:652–656CrossRef
13.
go back to reference Crandall MA, Bradley DJ, Packer DL, Asirvatham SJ (2009) Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies. Mayo Clin Proc 84:643–662CrossRefPubMedPubMedCentral Crandall MA, Bradley DJ, Packer DL, Asirvatham SJ (2009) Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies. Mayo Clin Proc 84:643–662CrossRefPubMedPubMedCentral
14.
go back to reference Gottlieb LK, Salem-Schatz S (1994) Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med 154:1945–1953CrossRefPubMed Gottlieb LK, Salem-Schatz S (1994) Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med 154:1945–1953CrossRefPubMed
15.
go back to reference Gallagher AM, Setakis E, Plumb JM, Clemens A, van Staa TP (2011) Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost 106:968–977CrossRefPubMed Gallagher AM, Setakis E, Plumb JM, Clemens A, van Staa TP (2011) Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost 106:968–977CrossRefPubMed
16.
go back to reference Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GY, Manning WJ (2008) Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:546s–592sCrossRefPubMed Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GY, Manning WJ (2008) Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:546s–592sCrossRefPubMed
17.
go back to reference Wysowski DK, Nourjah P, Swartz L (2007) Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med 167:1414–1419CrossRefPubMed Wysowski DK, Nourjah P, Swartz L (2007) Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med 167:1414–1419CrossRefPubMed
18.
go back to reference Brass LM, Krumholz HM, Scinto JM, Radford M (1997) Warfarin use among patients with atrial fibrillation. Stroke 28:2382–2389CrossRefPubMed Brass LM, Krumholz HM, Scinto JM, Radford M (1997) Warfarin use among patients with atrial fibrillation. Stroke 28:2382–2389CrossRefPubMed
19.
go back to reference Emmert MY, Puippe G, Baumuller S, Alkadhi H, Landmesser U, Plass A, Bettex D, Scherman J, Grunenfelder J, Genoni M, Falk V, Salzberg SP (2014) Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial. Eur J Cardiothorac Surg 45:126–131CrossRefPubMed Emmert MY, Puippe G, Baumuller S, Alkadhi H, Landmesser U, Plass A, Bettex D, Scherman J, Grunenfelder J, Genoni M, Falk V, Salzberg SP (2014) Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial. Eur J Cardiothorac Surg 45:126–131CrossRefPubMed
20.
go back to reference Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983–988CrossRefPubMed Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983–988CrossRefPubMed
21.
go back to reference Steger C, Pratter A, Martinek-Bregel M, Avanzini M, Valentin A, Slany J, Stollberger C (2004) Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry. Eur Heart J 25:1734–1740CrossRefPubMed Steger C, Pratter A, Martinek-Bregel M, Avanzini M, Valentin A, Slany J, Stollberger C (2004) Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry. Eur Heart J 25:1734–1740CrossRefPubMed
22.
go back to reference Castella M, Pereda D, Mestres CA, Gomez F, Quintana E, Mulet J (2010) Thoracoscopic pulmonary vein isolation in patients with atrial fibrillation and failed percutaneous ablation. J Thorac Cardiovasc Surg 140:633–638CrossRefPubMed Castella M, Pereda D, Mestres CA, Gomez F, Quintana E, Mulet J (2010) Thoracoscopic pulmonary vein isolation in patients with atrial fibrillation and failed percutaneous ablation. J Thorac Cardiovasc Surg 140:633–638CrossRefPubMed
23.
go back to reference Jiang Z, Yin H, He Y, Ma N, Tang M, Liu H, Ding F, Mei J (2014) Efficacy and safety of novel epicardial circumferential left atrial ablation with pulmonary vein isolation in sustained atrial fibrillation. Heart Vessels. doi:10.1007/s00380-014-0594-4 Jiang Z, Yin H, He Y, Ma N, Tang M, Liu H, Ding F, Mei J (2014) Efficacy and safety of novel epicardial circumferential left atrial ablation with pulmonary vein isolation in sustained atrial fibrillation. Heart Vessels. doi:10.​1007/​s00380-014-0594-4
24.
go back to reference Patterson E, Po SS, Scherlag BJ, Lazzara R (2005) Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm 2:624–631CrossRefPubMed Patterson E, Po SS, Scherlag BJ, Lazzara R (2005) Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm 2:624–631CrossRefPubMed
25.
go back to reference Blackshear JL, Johnson WD, Odell JA, Baker VS, Howard M, Pearce L, Stone C, Packer DL, Schaff HV (2003) Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J Am Coll Cardiol 42:1249–1252CrossRef Blackshear JL, Johnson WD, Odell JA, Baker VS, Howard M, Pearce L, Stone C, Packer DL, Schaff HV (2003) Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J Am Coll Cardiol 42:1249–1252CrossRef
Metadata
Title
Stroke prevention following modified endoscopic ablation and appendectomy for atrial fibrillation
Authors
Nan Ma
Zhaolei Jiang
Fei Chen
Hang Yin
Fangbao Ding
Ju Mei
Publication date
01-09-2016
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 9/2016
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-015-0749-y

Other articles of this Issue 9/2016

Heart and Vessels 9/2016 Go to the issue